The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,002.00
Bid: 2,006.00
Ask: 2,008.00
Change: -10.00 (-0.50%)
Spread: 2.00 (0.10%)
Open: 2,014.00
High: 2,024.00
Low: 1,994.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Pearson has positive first quarter, buys language app

Fri, 29th Apr 2022 08:25

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Pearson has agreed to buy Mondly, an online language learning platform. It provided no financial details, but said it expects the purchase to accelerate revenue growth for its English Language Learning division from 2023 onward. It expects mid-teens margins for the division by 2025.

"Mondly is a fast growing and profitable business that expands our reach and scale in the language learning market and drives growth for the company," said Pearson Chief Executive Andy Bird. "This acquisition is strategically important to the group as well as being accretive and driving shareholder returns."

Mondly offers learning of English and 40 other languages via its app and other digital products, including virtual reality.

Turning to its own recent trading, Pearson reported underlying sales growth of 7% in the first quarter. It reaffirmed its guidance for adjust operating profit in 2022.

Pearson added that its GBP350 million share buyback programme has begun, with GBP75 million already completed.

Pearson shares were up 2.2% early Friday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.5% at 7,545.66

----------

Hang Seng: up 3.4% at 20,959.08

Nikkei 225: Tokyo market closed for holiday

S&P/ASX 200: closed up 1.1% at 7,435.00

----------

DJIA: closed up 614.46 points, or 1.9%, at 33,916.39

S&P 500: closed up 103.54 points, or 2.5%, at 4,287.50

Nasdaq Composite: closed up 382.59 points, or 3.1%, at 12,871.53

----------

EUR: up at USD1.0542 (USD1.0524)

GBP: up at USD1.2530 (USD1.2458)

USD: down at JPY130.29 (JPY131.00)

Gold: up at USD1,911.36 per ounce (USD1,887.75)

Oil (Brent): up at USD108.39 a barrel (USD106.55)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Friday's key economic events still to come

Japan Showa Day. Financial markets closed.

1100 CEST EU gross domestic product

1100 CEST EU consumer price index

0830 EDT US personal income & outlays

1000 EDT US University of Michigan survey of consumers

----------

Annual UK house price growth slowed slightly in April but remained robust, according to figures from mortgage lender Nationwide. UK house prices rose 12% year-on-year in April, slowing from March's 14% climb. "Nevertheless, this is the 11th time in the past 12 months that the annual growth rate has been in double digits," Nationwide analyst Robert Gardner commented. On a monthly basis, the average UK house price climbed 0.3% to GBP267,620, from GBP265,312. In March, prices had risen 1.1% monthly. Gardner added: "Housing market activity has remained solid with mortgage approvals continuing to run above pre-Covid levels. Demand is being supported by robust labour market conditions, where employment growth has remained strong and the unemployment rate has fallen back to pre-pandemic lows."

----------

Ukrainian President Volodymyr Zelensky welcomed further US financial support as a "very important step". Zelensky thanked both US President Joe Biden and the American people for their help, expressing hope that the US Congress would "quickly support" the USD33 billion boost. "President Biden rightly said today that this step is not cheap," Zelensky said in his daily video address. "But the negative consequences of Russia's aggression against Ukraine and against democracy are so large-scale for the whole world that, in comparison with them, this support from the US is necessary. Together, we can certainly stop Russian aggression and reliably defend freedom in Europe." Of the latest sum, USD20 billion would be used for military aid while USD8.5 billion would be provided for economic aid. The US has pledged or already delivered weapons and ammunition worth more than USD3.7 billion to Ukraine since Moscow's attacks began in late February.

----------

BROKER RATING CHANGES

----------

JPMorgan cuts J Sainsbury price target to 190 (230) pence - 'underweight'

----------

RBC cuts Oxford Nanopore Technologies price target to 400 (700) pence - 'outperform'

----------

COMPANIES - FTSE 100

----------

NatWest rounded off the UK blue-chip banking earnings season with a slight flourish. Total income in the three months to March 31 climbed 17% annually to GBP3.03 billion from GBP2.59 billion. Operating pretax profit jumped 96% to GBP1.25 billion from GBP635 million. The lender expects to meet annual guidance, though there is an improved outlook for its 'Go-Forward' businesses, which exclude Ulster Bank Republic of Ireland. NatWest now expects total income, excluding notable items, at the "Go-Forward" units to be "comfortably above" GBP11.0 billion. Back in February, it only expected total income "above GBP11.0 billion", not "comfortably above". In addition, on Friday, AIB said it has entered into exclusive talks with NatWest to acquire EUR6 billion in Ulster Bank performing tracker mortgages. "Any potential transaction remains subject to negotiations and agreement," AIB added.

----------

Pharmaceutical firm AstraZeneca's got a boost from its acquisition of Alexion. AstraZeneca said its total revenue in the first three months of 2022 surged 56% to USD11.39 billion. The drugmaker's reported earnings per share fell 79% yearly, however, to USD0.25. Core EPS, which excludes acquisition-related items, amortisation of intangibles, impairments, and restructuring charges, was 16% higher at USD1.89. Astra said the revenue surge reflected "growth across the company, the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete delivery by half year 2022". AstraZeneca completed its USD39 billion takeover of Boston-based rare diseases firm Alexion Pharmaceuticals in July last year. Astra backed annual guidance. It tips revenue to rise "by a high teens percentage" and core EPS to climb by a "mid-to-high twenties percentage". Both growth rates are at constant currency. Astra has not given any guidance on a reported basis. It also said it plans to launch a new R&D site in Cambridge, Massachusetts.

----------

Generic drug maker Hikma Pharmaceuticals raised guidance for its key Injectables business due to the contribution from its acquisition of Custopharm. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. The deal added up to 13 approved products to Hikma's portfolio. The company said it now expects Injectables revenue growth in mid-to-high single digits in 2022, up from previous guidance of low-to-mid single digits. Generics revenue is expected to grow by 8% to 10% in 2022, while Branded revenue is expected to be in line with 2021.

----------

Reckitt Benckiser reported a slight revenue fall in the first quarter of 2022 but said it expects 2022 like-for-like net revenue growth at the upper end of its 1% to 4% guidance. "Despite significant cost inflation, we expect adjusted operating margins in-line with prior year and current market expectations," the Dettol and Air Wick owner said. Net revenue in the first quarter fell 2.3% year-on-year to GBP3.42 billion. On a like-for-like basis, it was up 5.6%. Hygiene arm revenue fell 9.0% like-for-like, though Nutrition surged 20% and Health jumped 21%.

----------

Oil major BP will partner with German automaker Volkswagen to "boost" adoption of electric vehicles across Europe. The pair plans to "rapidly" build fast-charging EV network across Europe by 2024. "Volkswagen's innovative Flexpole 150,000 watts charging units, each of which features two charge points, have an integrated battery storage system, overcoming one of the biggest obstacles to the rapid roll-out of fast charging infrastructure in Europe today – the need for high-powered grid connections," VW explained. First phase of the roll-out will see up to an additional 4,000 charge points at BP's Aral retail sites in Germany and BP retail sites in the UK over the next 24 months. The paid hope to make 8,000 charge points available across Europe by end of 2024.

----------

COMPANIES - SMALL CAP

----------

Electrical goods seller AO World said it is "cautious" about its revenue and profit outlook, amid supply chain pressures and the impact of inflation. In the year ended March 31, group revenue fell 6% year-on-year, though was up 52% from two years prior. A strategic review launched in January is continuing, AO World added.

----------

Building materials company Kingspan said first-quarter revenue surged, though inflationary pressures, which had ebbed slightly at the turn of the year, have returned in recent weeks. Kingspan's revenue in the first quarter of 2022 jumped 47% year-on-year to EUR1.89 billion. "Raw material inflation which had eased considerably at the turn of the year has returned sharply over the past six weeks and the associated recovery effort is ongoing," it cautioned. "The group's trading outlook for the second quarter is positive with a strong order backlog on hand and decent activity in most end-markets. Raw material inflation remains an issue to be firmly managed, coming on the back of a highly inflationary year in 2021."

----------

COMPANIES - GLOBAL

----------

BASF said first-quarter profit was hit by Russia-related impairment charges, despite healthy growth in sales. The Ludwigshafen, Germany-based chemical company said that, in the first quarter, sales grew 19% year-on-year to EUR23.08 billion from EUR19.40 billion. This was mainly driven by higher prices, notably in the Chemicals and Materials segments, which was somewhat offset by slightly lower sales volumes, BASF said. Earnings before interest and tax rose 19% to EUR2.8 billion, but pretax profit dropped 16% to EUR1.88 billion from EUR2.25 billion in the first quarter of 2021. The drop was due to impairment charges from Wintershall Dea, which caused a decline in income from shareholdings of EUR1.1 billion. The charges were caused by the war in Ukraine, and concerned assets in Russia and the gas transportation business.

----------

Friday's shareholder meetings

ADVFN PLC - GM re director appointments

AstraZeneca PLC - AGM

BBGI Global Infrastructure SA - AGM

GreenCoat Renewables PLC - AGM

Holders Technology PLC - AGM

HSBC Holdings PLC - AGM

JPMorgan Claverhouse Investment Trust PLC - AGM

Kingspan Group PLC - AGM

Minoan Group PLC - AGM

Nostrum Oil & Gas PLC - GM - re notes restructuring

Pearson PLC - AGM

Photo-Me International PLC - AGM

Rotork PLC - AGM

Smurfit Kappa Group PLC - AGM

Travis Perkins PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.